Walleye Trading
ACOR

Walleye Trading’s Acorda Therapeutics ACOR Stock Holding History

Walleye Trading’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-25
Closed -$6K – 4742
2019
Q4 		$6K Sell
25
-376
-94% -$94.9K ﹤0.01% 4103
2019
Q3 		$138K Buy
401
+38
+10% +$20.7K ﹤0.01% 3167
2019
Q2 		$334K Buy
363
+361
+18,050% +$444K ﹤0.01% 2518
2019
Q1 		$3K Buy
+2
New +$3.6K ﹤0.01% 4077
2018
Q3 		– Sell
-121
Closed -$375K – 5640
2018
Q2 		$417K Buy
121
+99
+450% +$303K ﹤0.01% 3002
2018
Q1 		$61K Buy
+22
New +$65.9K ﹤0.01% 4086
2017
Q3 		– Sell
-4
Closed -$10 – 4720
2017
Q2 		$10 Sell
4
-332
-99% -$658K ﹤0.01% 4251
2017
Q1 		$846 Sell
336
-162
-33% -$466K 0.01% 1781
2016
Q4 		$1.12M Buy
+498
New +$1.18M 0.01% 1424
2016
Q3 		– Sell
-6
Closed -$18K – 5578
2016
Q2 		$18K Buy
6
+5
+500% +$16.3K ﹤0.01% 4626
2016
Q1 		$3K Buy
+1
New +$4.15K ﹤0.01% 5072

Other funds holding ACOR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Walleye Trading's ACOR Position: Q1 2020 in Review

Walleye Trading sold out of Acorda Therapeutics (ACOR) in Q1 2020, closing a stake of 25 shares — an estimated $6K sold.

Walleye Trading first reported a position in ACOR in Q1 2016 and held it in 11 quarters. The position peaked at $1.12M in Q4 2016. 106 funds tracked by Wall St. Rank hold ACOR as of Q1 2020.

  • Walleye Trading reported no remaining Acorda Therapeutics position as of Q1 2020 after selling out during the quarter.
  • Walleye Trading sold 25 Acorda Therapeutics shares in Q1 2020, an estimated $6K.
  • Walleye Trading first reported a position in Acorda Therapeutics in Q1 2016 and held it in 11 quarters.
  • Walleye Trading's Acorda Therapeutics position peaked at $1.12M in Q4 2016.
  • 106 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q1 2020.

Based on Walleye Trading's 13F filing for Q1 2020, filed 15 May 2020.